Sialoside-based pattern recognitions discriminating infections from tissue injuries

Current Opinion in Immunology

Volumn 23, Issue 1, 2011, Pages 41-45

  Liu, Yang ^a   Chen, Guo Yun ^a   Zheng, Pan ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD24 ANTIGEN; INTERLEUKIN 1BETA; INTERLEUKIN 8; MITOCHONDRIAL DNA; SIALIDASE; THIOREDOXIN INTERACTING PROTEIN;

CYTOKINE PRODUCTION; CYTOKINE RELEASE; DANGER ASSOCIATED MOLECULAR PATTERN; GENE FUNCTION; GENE MUTATION; GENE OVEREXPRESSION; GLYCOSYLATION; IMMUNE RESPONSE; IMMUNOREGULATION; INFECTION; INNATE IMMUNITY; NONHUMAN; PATHOGEN ASSOCIATED MOLECULAR PATTERN; PATTERN RECOGNITION; REVIEW; T LYMPHOCYTE ACTIVATION; TISSUE INJURY;

ANIMALS; ANTIGENS, CD24; HUMANS; IMMUNITY, INNATE; INFECTION; SUGAR ACIDS;

EID: 79951676227     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coi.2010.10.004     Document Type: Review

References (51)

1. Janeway C.A. Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb Symp Quant Biol 1989, 54:1-13.
2. Janeway C.A. The immune system evolved to discriminate infectious nonself from noninfectious self. Immunol Today 1992, 13:11-16.
3. Medzhitov R. Approaching the asymptote: 20 years later. Immunity 2009, 30:766-775.
4. Matzinger P. Tolerance, danger, and the extended family. Annu Rev Immunol 1994, 12:991-1045.
5. Apetoh L., Ghiringhelli F., Tesniere A., Obeid M., Ortiz C., Criollo A., Mignot G., Maiuri M.C., Ullrich E., Saulnier P., et al. Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nat Med 2007, 13:1050-1059.
6. Millar D.G., Garza K.M., Odermatt B., Elford A.R., Ono N., Li Z., et al. Hsp70 promotes antigen-presenting cell function and converts T-cell tolerance to autoimmunity in vivo. Nat Med 2003, 9:1469-1476.
7. Dostert C., Petrilli V., Van Bruggen R., Steele C., Mossman B.T., Tschopp J. Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science 2008, 320:674-677.
8. Germani A., Limana F., Capogrossi M.C. Pivotal advances: high-mobility group box 1 protein-a cytokine with a role in cardiac repair. J Leukoc Biol 2007, 81:41-45.
9. Palumbo R., Galvez B.G., Pusterla T., De Marchis F., Cossu G., Marcu K.B., Bianchi M.E. Cells migrating to sites of tissue damage in response to the danger signal HMGB1 require NF-kappaB activation. J Cell Biol 2007, 179:33-40.
10. Palumbo R., Sampaolesi M., De Marchis F., Tonlorenzi R., Colombetti S., Mondino A., Cossu G., Bianchi M.E. Extracellular HMGB1, a signal of tissue damage, induces mesoangioblast migration and proliferation. J Cell Biol 2004, 164:441-449.
11. Kono H., Rock K.L. How dying cells alert the immune system to danger. Nat Rev Immunol 2008, 8:279-289.
12. Ting J.P., Willingham S.B., Bergstralh D.T. NLRs at the intersection of cell death and immunity. Nat Rev Immunol 2008, 8:372-379.
13. Kawai T., Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 2010, 11:373-384.
14. Zhang Q., Raoof M., Chen Y., Sumi Y., Sursal T., Junger W., Brohi K., Itagaki K., Hauser C.J. Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 2010, 464:104-107.
15. Crow Y.J., Rehwinkel J. Aicardi-Goutieres syndrome and related phenotypes: linking nucleic acid metabolism with autoimmunity. Hum Mol Genet 2009, 18:R130-R136.
16. Stetson D.B., Ko J.S., Heidmann T., Medzhitov R. Trex1 prevents cell-intrinsic initiation of autoimmunity. Cell 2008, 134:587-598.
17. Hornung V., Bauernfeind F., Halle A., Samstad E.O., Kono H., Rock K.L., Fitzgerald K.A., Latz E. Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat Immunol 2008, 9:847-856.
18. Cassel S.L., Eisenbarth S.C., Iyer S.S., Sadler J.J., Colegio O.R., Tephly L.A., Carter A.B., Rothman P.B., Flavell R.A., Sutterwala F.S. The Nalp3 inflammasome is essential for the development of silicosis. Proc Natl Acad Sci U S A 2008, 105:9035-9040.
19. Duewell P., Kono H., Rayner K.J., Sirois C.M., Vladimer G., Bauernfeind F.G., Abela G.S., Franchi L., Nunez G., Schnurr M., et al. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 2010, 464:1357-1361.
20. Tschopp J., Schroder K. NLRP3 inflammasome activation: the convergence of multiple signalling pathways on ROS production?. Nat Rev Immunol 2010, 10:210-215.
21. Eisenbarth S.C., Colegio O.R., O'Connor W., Sutterwala F.S., Flavell R.A. Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants. Nature 2008, 453:1122-1126.
22. Li H., Willingham S.B., Ting J.P., Re F. Cutting edge: inflammasome activation by alum and alum's adjuvant effect are mediated by NLRP3. J Immunol 2008, 181:17-21.
23. Kool M., Petrilli V., De Smedt T., Rolaz A., Hammad H., van Nimwegen M., Bergen I.M., Castillo R., Lambrecht B.N., Tschopp J. Cutting edge: alum adjuvant stimulates inflammatory dendritic cells through activation of the NALP3 inflammasome. J Immunol 2008, 181:3755-3759.
24. McKee A.S., Munks M.W., MacLeod M.K., Fleenor C.J., Van Rooijen N., Kappler J.W., Marrack P. Alum induces innate immune responses through macrophage and mast cell sensors, but these sensors are not required for alum to act as an adjuvant for specific immunity. J Immunol 2009, 183:4403-4414.
25. Franchi L., Nunez G. The Nlrp3 inflammasome is critical for aluminium hydroxide-mediated IL-1beta secretion but dispensable for adjuvant activity. Eur J Immunol 2008, 38:2085-2089.
26. Liew F.Y., Xu D., Brint E.K., O'Neill L.A. Negative regulation of toll-like receptor-mediated immune responses. Nat Rev Immunol 2005, 5:446-458.
27. Powell L.D., Whiteheart S.W., Hart G.W. Cell surface sialic acid influences tumor cell recognition in the mixed lymphocyte reaction. J Immunol 1987, 139:262-270.
28. Jarahian M., Watzl C., Fournier P., Arnold A., Djandji D., Zahedi S., Cerwenka A., Paschen A., Schirrmacher V., Momburg F. Activation of natural killer cells by Newcastle disease virus hemagglutinin-neuraminidase. J Virol 2009, 83:8108-8121.
29. Muller E., Schroder C., Schauer R., Sharon N. Binding and phagocytosis of sialidase-treated rat erythrocytes by a mechanism independent of opsonins. Hoppe Seylers Z Physiol Chem 1983, 364:1419-1429.
30. Crocker P.R., Gordon S. Mouse macrophage hemagglutinin (sheep erythrocyte receptor) with specificity for sialylated glycoconjugates characterized by a monoclonal antibody. J Exp Med 1989, 169:1333-1346.
31. Crocker P.R., Clark E.A., Filbin M., Gordon S., Jones Y., Kehrl J.H., Kelm S., Le Douarin N., Powell L., Roder J., et al. Siglecs: a family of sialic-acid binding lectins. Glycobiology 1998, 8:v.
32. Crocker P.R., Paulson J.C., Varki A. Siglecs and their roles in the immune system. Nat Rev Immunol 2007, 7:255-266.
33. Ding C., Liu Y., Wang Y., Park B.K., Wang C.Y., Zheng P., Liu Y. Siglecg limits the size of B1a B cell lineage by down-regulating NFkappaB activation. PLoS One 2007, 2:e997.
34. Hoffmann A., Kerr S., Jellusova J., Zhang J., Weisel F., Wellmann U., Winkler T.H., Kneitz B., Crocker P.R., Nitschke L. Siglec-G is a B1 cell-inhibitory receptor that controls expansion and calcium signaling of the B1 cell population. Nat Immunol 2007, 8:695-704.
35. Chen G.Y., Tang J., Zheng P., Liu Y. CD24 and Siglec-10 selectively repress tissue damage-induced immune responses. Science 2009, 323:1722-1725.
36. Motari E., Zheng X., Su X., Liu Y., Kvaratskhelia M., Freitas M., Wang P.G. Analysis of recombinant CD24 glycans by MALDI-TOF-MS reveals prevalence of sialyl-T antigen. Am J Biomed Sci 2009, 1:1-11.
37. Bleckmann C., Geyer H., Reinhold V., Lieberoth A., Schachner M., Kleene R., Geyer R. Glycomic analysis of N-linked carbohydrate epitopes from CD24 of mouse brain. J Proteome Res 2009, 8:567-582.
38. Vimr E.R. Microbial sialidases: does bigger always mean better?. Trends Microbiol 1994, 2:271-277.
39. Kakugawa Y., Wada T., Yamaguchi K., Yamanami H., Ouchi K., Sato I., Miyagi T. Up-regulation of plasma membrane-associated ganglioside sialidase (Neu3) in human colon cancer and its involvement in apoptosis suppression. Proc Natl Acad Sci U S A 2002, 99:10718-10723.
40. Miyagi T., Wada T., Yamaguchi K., Shiozaki K., Sato I., Kakugawa Y., Yamanami H., Fujiya T. Human sialidase as a cancer marker. Proteomics 2008, 8:3303-3311.
41. Ueno S., Saito S., Wada T., Yamaguchi K., Satoh M., Arai Y., Miyagi T. Plasma membrane-associated sialidase is up-regulated in renal cell carcinoma and promotes interleukin-6-induced apoptosis suppression and cell motility. J Biol Chem 2006, 281:7756-7764.
42. Valaperta R., Valsecchi M., Rocchetta F., Aureli M., Prioni S., Prinetti A., Chigorno V., Sonnino S. Induction of axonal differentiation by silencing plasma membrane-associated sialidase Neu3 in neuroblastoma cells. J Neurochem 2007, 100:708-719.
43. Nomura H., Tamada Y., Miyagi T., Suzuki A., Taira M., Suzuki N., Susumu N., Irimura T., Aoki D. Expression of NEU3 (plasma membrane-associated sialidase) in clear cell adenocarcinoma of the ovary: its relationship with T factor of pTNM classification. Oncol Res 2006, 16:289-297.
44. Carlin A.F., Uchiyama S., Chang Y.C., Lewis A.L., Nizet V., Varki A. Molecular mimicry of host sialylated glycans allows a bacterial pathogen to engage neutrophil Siglec-9 and DAMPsen the innate immune response. Blood 2009, 113:3333-3336.
45. Belisle J.A., Horibata S., Jennifer G.A., Petrie S., Kapur A., Andre S., Gabius H.J., Rancourt C., Connor J., Paulson J.C., Patankar M.S. Identification of Siglec-9 as the receptor for MUC16 on human NK cells, B cells, and monocytes. Mol Cancer 2010, 9:118.
46. Avril T., Floyd H., Lopez F., Vivier E., Crocker P.R. The membrane-proximal immunoreceptor tyrosine-based inhibitory motif is critical for the inhibitory signaling mediated by Siglecs-7 and -9, CD33-related Siglecs expressed on human monocytes and NK cells. J Immunol 2004, 173:6841-6849.
47. Sanchez E., Abelson A.K., Sabio J.M., Gonzalez-Gay M.A., Ortego-Centeno N., Jimenez-Alonso J., de Ramon E., Sanchez-Roman J., Lopez-Nevot M.A., Gunnarsson I., et al. Association of a CD24 gene polymorphism with susceptibility to systemic lupus erythematosus. Arthritis Rheum 2007, 56:3080-3086.
48. Sanchez E., Fernandez-Gutierrez B., Gonzalez-Gay M.A., Balsa A., Garcia A., Rodriguez L., Pascual-Salcedo D., Gonzalez-Escribano M.F., Martin J. Investigating the role of CD24 gene polymorphisms in rheumatoid arthritis. Ann Rheum Dis 2008, 67:1197-1198.
49. Wang L., Lin S., Rammohan K., Liu Z., Liu J., Liu R.-H., Guinther N., Zhou Q., Wang T., Zheng X., et al. A di-nucleotide deletion in CD24 confers protection against autoimmune diseases. PLoS Genet 2007, 3:e49.
50. Zhou Q., Rammohan K., Lin S., Robinson N., Li O., Liu X., Bai X.F., Yin L., Scarberry B., Du P., et al. CD24 is a genetic modifier for risk and progression of multiple sclerosis. Proc Natl Acad Sci U S A 2003, 100:15041-15046.
51. Surolia I., Pirnie S.P., Chellappa V., Taylor K.N., Cariappa A., Moya J., Liu H., Bell D.W., Driscoll D.R., Diederichs S., et al. Functionally defective germline variants of sialic acid acetylesterase in autoimmunity. Nature 2010, 466:243-247.